Latest Commercialization News

Kore Potash has signed a landmark $1.929 billion fixed-price EPC contract for its Kola Potash Project, reinforcing its strategy to become a low-cost producer. The company is now awaiting a financing proposal from the Summit Consortium expected by February 2025.

Atlantic Lithium has cleared critical regulatory hurdles for its Ewoyaa Lithium Project in Ghana, securing key permits and raising A$10 million to advance construction plans. The company also updated its feldspar resource estimate, underscoring the project's growing commercial potential.

Green Critical Minerals has made significant strides in commercialising its Very High-Density (VHD) Graphite technology, achieving exceptional pilot plant results and positioning itself at the forefront of clean energy and electronics markets.

EcoGraf Limited advances its vertically integrated battery anode materials business with a significant UFK loan mandate and progress across upstream, midstream, and downstream operations.

Critica Limited reports exceptional progress at its Jupiter Project, highlighted by record-breaking drilling results and a significant rare earths concentrate upgrade, with a maiden Mineral Resource Estimate due mid-February 2025.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.

Impact Minerals reports a maiden Measured Resource at its Lake Hope High Purity Alumina Project and secures $2.87 million in government funding to accelerate pilot plant development, while progressing exploration and IPO plans for other assets.

Firebird Metals Limited has secured preliminary design approval for its battery-grade manganese sulphate plant in China and forged a strategic partnership to develop LMFP cathode materials, marking significant progress in its EV battery ambitions.

NH3 Clean Energy has made significant strides in its WAH2 Project, finalising critical commercial agreements and progressing technical work ahead of Front End Engineering and Design (FEED) entry scheduled for Q1 2025. The company also completed a capital raise to support these developments.

Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.

Echo IQ Limited has secured FDA clearance for its EchoSolv AS technology and appointed a US-based CEO, marking a pivotal shift towards commercialisation in the American healthcare market.